Cargando…

Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study

BACKGROUND: Home-management of malaria (HMM) strategy improves early access of anti-malarial medicines to high-risk groups in remote areas of sub-Saharan Africa. However, limited data are available on the effectiveness of using artemisinin-based combination therapy (ACT) within the HMM strategy. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngasala, Billy E, Malmberg, Maja, Carlsson, Anja M, Ferreira, Pedro E, Petzold, Max G, Blessborn, Daniel, Bergqvist, Yngve, Gil, José P, Premji, Zul, Mårtensson, Andreas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065443/
https://www.ncbi.nlm.nih.gov/pubmed/21410954
http://dx.doi.org/10.1186/1475-2875-10-64
_version_ 1782200982522822656
author Ngasala, Billy E
Malmberg, Maja
Carlsson, Anja M
Ferreira, Pedro E
Petzold, Max G
Blessborn, Daniel
Bergqvist, Yngve
Gil, José P
Premji, Zul
Mårtensson, Andreas
author_facet Ngasala, Billy E
Malmberg, Maja
Carlsson, Anja M
Ferreira, Pedro E
Petzold, Max G
Blessborn, Daniel
Bergqvist, Yngve
Gil, José P
Premji, Zul
Mårtensson, Andreas
author_sort Ngasala, Billy E
collection PubMed
description BACKGROUND: Home-management of malaria (HMM) strategy improves early access of anti-malarial medicines to high-risk groups in remote areas of sub-Saharan Africa. However, limited data are available on the effectiveness of using artemisinin-based combination therapy (ACT) within the HMM strategy. The aim of this study was to assess the effectiveness of artemether-lumefantrine (AL), presently the most favoured ACT in Africa, in under-five children with uncomplicated Plasmodium falciparum malaria in Tanzania, when provided by community health workers (CHWs) and administered unsupervised by parents or guardians at home. METHODS: An open label, single arm prospective study was conducted in two rural villages with high malaria transmission in Kibaha District, Tanzania. Children presenting to CHWs with uncomplicated fever and a positive rapid malaria diagnostic test (RDT) were provisionally enrolled and provided AL for unsupervised treatment at home. Patients with microscopy confirmed P. falciparum parasitaemia were definitely enrolled and reviewed weekly by the CHWs during 42 days. Primary outcome measure was PCR corrected parasitological cure rate by day 42, as estimated by Kaplan-Meier survival analysis. This trial is registered with ClinicalTrials.gov, number NCT00454961. RESULTS: A total of 244 febrile children were enrolled between March-August 2007. Two patients were lost to follow up on day 14, and one patient withdrew consent on day 21. Some 141/241 (58.5%) patients had recurrent infection during follow-up, of whom 14 had recrudescence. The PCR corrected cure rate by day 42 was 93.0% (95% CI 88.3%-95.9%). The median lumefantrine concentration was statistically significantly lower in patients with recrudescence (97 ng/mL [IQR 0-234]; n = 10) compared with reinfections (205 ng/mL [114-390]; n = 92), or no parasite reappearance (217 [121-374] ng/mL; n = 70; p ≤ 0.046). CONCLUSIONS: Provision of AL by CHWs for unsupervised malaria treatment at home was highly effective, which provides evidence base for scaling-up implementation of HMM with AL in Tanzania.
format Text
id pubmed-3065443
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30654432011-03-29 Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study Ngasala, Billy E Malmberg, Maja Carlsson, Anja M Ferreira, Pedro E Petzold, Max G Blessborn, Daniel Bergqvist, Yngve Gil, José P Premji, Zul Mårtensson, Andreas Malar J Research BACKGROUND: Home-management of malaria (HMM) strategy improves early access of anti-malarial medicines to high-risk groups in remote areas of sub-Saharan Africa. However, limited data are available on the effectiveness of using artemisinin-based combination therapy (ACT) within the HMM strategy. The aim of this study was to assess the effectiveness of artemether-lumefantrine (AL), presently the most favoured ACT in Africa, in under-five children with uncomplicated Plasmodium falciparum malaria in Tanzania, when provided by community health workers (CHWs) and administered unsupervised by parents or guardians at home. METHODS: An open label, single arm prospective study was conducted in two rural villages with high malaria transmission in Kibaha District, Tanzania. Children presenting to CHWs with uncomplicated fever and a positive rapid malaria diagnostic test (RDT) were provisionally enrolled and provided AL for unsupervised treatment at home. Patients with microscopy confirmed P. falciparum parasitaemia were definitely enrolled and reviewed weekly by the CHWs during 42 days. Primary outcome measure was PCR corrected parasitological cure rate by day 42, as estimated by Kaplan-Meier survival analysis. This trial is registered with ClinicalTrials.gov, number NCT00454961. RESULTS: A total of 244 febrile children were enrolled between March-August 2007. Two patients were lost to follow up on day 14, and one patient withdrew consent on day 21. Some 141/241 (58.5%) patients had recurrent infection during follow-up, of whom 14 had recrudescence. The PCR corrected cure rate by day 42 was 93.0% (95% CI 88.3%-95.9%). The median lumefantrine concentration was statistically significantly lower in patients with recrudescence (97 ng/mL [IQR 0-234]; n = 10) compared with reinfections (205 ng/mL [114-390]; n = 92), or no parasite reappearance (217 [121-374] ng/mL; n = 70; p ≤ 0.046). CONCLUSIONS: Provision of AL by CHWs for unsupervised malaria treatment at home was highly effective, which provides evidence base for scaling-up implementation of HMM with AL in Tanzania. BioMed Central 2011-03-16 /pmc/articles/PMC3065443/ /pubmed/21410954 http://dx.doi.org/10.1186/1475-2875-10-64 Text en Copyright ©2011 Ngasala et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ngasala, Billy E
Malmberg, Maja
Carlsson, Anja M
Ferreira, Pedro E
Petzold, Max G
Blessborn, Daniel
Bergqvist, Yngve
Gil, José P
Premji, Zul
Mårtensson, Andreas
Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study
title Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study
title_full Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study
title_fullStr Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study
title_full_unstemmed Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study
title_short Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study
title_sort effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural tanzania: an open label prospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065443/
https://www.ncbi.nlm.nih.gov/pubmed/21410954
http://dx.doi.org/10.1186/1475-2875-10-64
work_keys_str_mv AT ngasalabillye effectivenessofartemetherlumefantrineprovidedbycommunityhealthworkersinunderfivechildrenwithuncomplicatedmalariainruraltanzaniaanopenlabelprospectivestudy
AT malmbergmaja effectivenessofartemetherlumefantrineprovidedbycommunityhealthworkersinunderfivechildrenwithuncomplicatedmalariainruraltanzaniaanopenlabelprospectivestudy
AT carlssonanjam effectivenessofartemetherlumefantrineprovidedbycommunityhealthworkersinunderfivechildrenwithuncomplicatedmalariainruraltanzaniaanopenlabelprospectivestudy
AT ferreirapedroe effectivenessofartemetherlumefantrineprovidedbycommunityhealthworkersinunderfivechildrenwithuncomplicatedmalariainruraltanzaniaanopenlabelprospectivestudy
AT petzoldmaxg effectivenessofartemetherlumefantrineprovidedbycommunityhealthworkersinunderfivechildrenwithuncomplicatedmalariainruraltanzaniaanopenlabelprospectivestudy
AT blessborndaniel effectivenessofartemetherlumefantrineprovidedbycommunityhealthworkersinunderfivechildrenwithuncomplicatedmalariainruraltanzaniaanopenlabelprospectivestudy
AT bergqvistyngve effectivenessofartemetherlumefantrineprovidedbycommunityhealthworkersinunderfivechildrenwithuncomplicatedmalariainruraltanzaniaanopenlabelprospectivestudy
AT giljosep effectivenessofartemetherlumefantrineprovidedbycommunityhealthworkersinunderfivechildrenwithuncomplicatedmalariainruraltanzaniaanopenlabelprospectivestudy
AT premjizul effectivenessofartemetherlumefantrineprovidedbycommunityhealthworkersinunderfivechildrenwithuncomplicatedmalariainruraltanzaniaanopenlabelprospectivestudy
AT martenssonandreas effectivenessofartemetherlumefantrineprovidedbycommunityhealthworkersinunderfivechildrenwithuncomplicatedmalariainruraltanzaniaanopenlabelprospectivestudy